Leading Enteric Disease Testing Country Markets Databank
The Enteric Disease Testing market was valued at $1,725.2 Million in 2020, and is projected to reach $2,559.3 Million by 2029 growing at a CAGR of 4.53% from 2021 to 2029. North America is expected to be the highest contributor to this market, with $572.8 Million in 2020, and is anticipated to reach $707.0 Million by 2029, registering a CAGR of 2.40%. Asia-Pacific is anticipated to reach $715.5 Million by 2029 with the highest CAGR of 6.07%. North America and Europe collectively expected to account for about 61.6% share of the Enteric Disease Testing market in 2020, with the former constituting around 33.2% share. Asia-Pacific and Europe are expected to witness significant growth rates at a CAGR of 6.07% and 5.25% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 52.9% in the overall Enteric Disease Testing market in 2020, and is anticipated to reach 58.2% by 2029.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook